Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations (Unaudited)

v3.26.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Revenue        
Total revenue $ 90 $ 35,000 $ 90
Operating expenses:        
Research and development, net of reimbursements 4,707 4,248 14,285 16,827
General and administrative 1,415 1,534 5,175 13,096
Total operating expenses 6,122 5,782 19,460 29,923
Income/(Loss) from operations (6,122) (5,692) 15,540 (29,833)
Other income:        
Interest income - net 279 561 996 1,886
Total other income 279 561 996 1,886
Income/(loss) before income taxes (5,843) (5,131) 16,536 (27,947)
Income tax expense
Net income/(loss) $ (5,843) $ (5,131) $ 16,536 $ (27,947)
Net income/(loss) per common share – basic (in Dollars per share) $ (0.19) $ (0.16) $ 0.53 $ (0.9)
Weighted average common shares outstanding – basic (in Shares) 31,441,436 31,195,891 31,360,148 31,195,891
Net income/(loss) per common share – diluted (in Dollars per share) $ (0.19) $ (0.16) $ 0.53 $ (0.9)
Weighted average common shares outstanding – diluted (in Shares) 31,441,436 31,195,891 31,377,089 31,195,891
Revenue        
Revenue        
Total revenue
Other Revenue        
Revenue        
Total revenue $ 90 $ 35,000 $ 90